Portfolio Lab

Neogen Corp

  • Stock
  • Ticker NEOG
  • ISIN US6404911066
  • Nasdaq

Health care · Diagnostics · USA

$10.55 −2.76%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Neogen Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

NEOGGlobal equities (VT)

$10,000 grew to $4,544. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −90.9% in 04/2025, measured from the peak in 04/2021. The old peak has not been reached again yet.

1-year return
+95.0%
5-year return p.a.
−24.8%
10-year return p.a.
−7.6%
Volatility p.a.
45.1%
Largest decline
−90.9%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end11/202402/202505/202508/202511/202502/202605/202608/2026
Income statement
Revenue231221226209225211225223
Gross profit113110939510799108106
Operating income-4575.4-611-16-5.4-3.33.1-1.8
EBITDA-42735-5811324263327
Net income-456-11-61236-16-17-11-12
Earnings per share-2.10-0.05-2.820.17-0.07-0.08-0.06-0.05
Balance sheet
Total assets4,0544,0363,4443,3783,3603,3593,3463,303
Liabilities1,3851,3761,3731,2601,2551,2571,2531,217
Equity2,6692,6602,0712,1192,1042,1022,0932,086
Cash140128129139145160186172
Long-term debt890891875793793793794774
Cash flow
Operating cash flow4019161119233013
Capital expenditure-17-33-16-24-12-12-4.0-8.2
Free cash flow23-130.3-137.811264.7

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2023 at +32.0%, weakest 2022 at −66.5%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
7 Oct 2026−$0.05
30 Jul 2026−$0.06
9 Apr 2026−$0.08
8 Jan 2026−$0.07
9 Oct 2025$0.17
30 Jul 2025−$2.82
9 Apr 2025−$0.05
15 Jan 2025−$2.10
10 Oct 2024−$0.06
30 Jul 2024−$0.02
9 Apr 2024−$0.01
9 Jan 2024−$0.02

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€2.1bn
Market cap in trading currency
$2.30bn
Enterprise value
$2.91bn
P/E
–
P/S
2.61
P/B
1.10
EV/Sales
3.29
EV/EBITDA
26.7
Earnings yield
–
FCF yield
2.2%

Results (last four quarters)

Revenue
$884m
Gross profit
$419m
EBITDA
$109m
Net income
−$56.1m
Earnings per share
−$0.26
Revenue per share
$4.05
Revenue growth
+6.5%
Earnings growth
−132.8%

Profitability

Gross margin
47.4%
Operating margin
-0.8%
Net margin
-6.3%
Return on equity
-2.7%
Return on assets
-1.7%

Balance sheet and cash flow

Cash
$172m
Cash per share
$0.79
Financial debt
$774m
Debt/equity %
37
Current ratio
3.90
Book value per share
$9.56
Operating cash flow
$85.3m
Free cash flow
$49.8m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
218m
Volume
3.04m
Avg. volume 3 months
3.49m
Relative volume
0.9

Price and technicals

Price
$10.55
1 day
−2.8%
52-week high
$13.98
52-week low
$5.41
Distance to 52-week high
−24.5%
Distance to 52-week low
+95.0%
Distance to 50-day line
−13.1%
Distance to 200-day line
+0.2%
RSI (14)
34
Volatility 1M
41.5%

Performance

1 week
−6.1%
1 month
−11.9%
3 months
−9.1%
6 months
+18.5%
YTD
+50.9%
1 year
+89.4%

Dates

Fiscal year end
31 May 2026
Most recent quarter
31 Aug 2026

Frequently asked questions

How has NEOG performed since 11/2016?

$10,000 grew to $4,543 by 20 Nov 2026, which is −7.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is NEOG?

Volatility was 45.1% per year, measured on monthly returns. The largest decline from a peak was −90.9%, with the low in 04/2025.

How does NEOG compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, NEOG returned −7.6% at 45.1%. The correlation of monthly returns was 0.43; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Neogen Corp (NEOG): Return and risk | Portfolio Lab